Tetanus Antitoxoid
Also known as: Tetanus Toxin Antibody, Tetanus Toxoid Antibody
Use
This test assesses serum antibody levels to Tetanus Antitoxoid. Immunization with tetanus antitoxoid is effective with booster vaccinations in immunocompetent individuals. Antibody levels ≥ 0.10 IU/mL are considered protective, although tetanus may still occur in individuals with such levels. Results should not be used to determine the necessity of antitoxin administration when clinically indicated. (Quest Diagnostics proprietary assay performance; not FDA-cleared.)
Special Instructions
Not provided.
Limitations
This test was developed by Quest Diagnostics; its analytical performance characteristics have been determined by Quest. It has not been cleared or approved by the FDA. The assay has been validated pursuant to CLIA regulations and is used for clinical purposes.
Methodology
Immunoassay (ELISA)
Biomarkers
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
0.3 mL
Container
Serum separator tube or plain red tube
Collection Instructions
Centrifuge the serum separator tube; if plain red, centrifuge and aliquot 1 mL serum.
Causes for Rejection
Gross hemolysis, gross lipemia, grossly icteric.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |